Brief: Virios Therapeutics Announces Third Quarter 2021 Financial Results
11/11/2021 12:12
Nov 11 (Reuters) - Virios Therapeutics Inc VIRI.O :
* VIRIOS THERAPEUTICS ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q3 LOSS PER SHARE $0.49
* BELIEVES IT WILL HAVE SUFFICIENT RESOURCES TO FUND PLANNED
OPERATIONS INTO Q1 2023
Source text for Eikon: ID:nBwyhr9qa
Further company coverage: VIRI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Dogwood Therapeutics
See all newsDogwood Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Dogwood Therapeutics Q2 net loss widens on higher costs, impairment charge
Brief: Dogwood Therapeutics Q2 EPS USD -0.34
Dogwood Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Dogwood Therapeutics Announces Commencement Of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2B Long Term Extension Study